
IMVIQ
Healthcare · Biotechnology · $11 market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2023
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 16, 2023 | Before the open | -1.20 | -0.99 | +17.5% |
| Nov 10, 2022 | Time not confirmed | -0.14 | -0.11 | +21.4% |
| Aug 11, 2022 | Time not confirmed | -0.13 | -0.12 | +6.9% |
| May 13, 2022 | Time not confirmed | -0.14 | -0.13 | +4.6% |
| Mar 17, 2022 | Time not confirmed | -0.14 | -0.15 | -9.2% |
| Nov 10, 2021 | Time not confirmed | -0.12 | -0.13 | -10.4% |
| Aug 11, 2021 | Time not confirmed | -0.12 | -0.11 | +9.3% |
| May 12, 2021 | Time not confirmed | -0.13 | -0.10 | +22.6% |
| Mar 17, 2021 | Time not confirmed | -0.11 | -0.10 | +6.7% |
| Nov 12, 2020 | Time not confirmed | -0.09 | -0.10 | -16.2% |
| Aug 12, 2020 | Time not confirmed | -0.12 | -0.10 | +18.2% |
| May 15, 2020 | Time not confirmed | -0.11 | -0.14 | -22.7% |
| Mar 30, 2020 | Time not confirmed |
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian…
| -0.10 |
| -0.11 |
| -12.4% |
| Nov 8, 2019 | Time not confirmed | -0.09 | -0.12 | -34.6% |
| Aug 8, 2019 | Time not confirmed | -0.10 | -0.08 | +24.5% |
| May 11, 2019 | Time not confirmed | -0.10 | -0.10 | +3.3% |
| Mar 21, 2019 | Time not confirmed | -0.13 | -0.13 | +2.5% |
| Nov 2, 2018 | Time not confirmed | -0.06 | -0.11 | -78.0% |
| Aug 8, 2018 | Time not confirmed | -0.06 | -0.12 | -100.0% |
| May 15, 2018 | Time not confirmed | -0.64 | -0.05 | +91.4% |
| Mar 23, 2018 | Time not confirmed | -0.64 | -0.13 | +79.2% |